| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.25 | 0.06 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.23 | 0.07 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |